Thu May 15 05:12:29 UTC 2025: Okay, here’s a news article summary based on the provided text:
**Bengaluru Firm Launches Global Cancer Diversity Atlas to Address Genomic Data Gap**
**Bengaluru, India – May 15, 2025** – A Bengaluru-based private firm, 4baseCare, has launched the Global Cancer Diversity Atlas (GCDA), aiming to address the significant underrepresentation of non-Western populations in cancer genomic data. The atlas, unveiled on May 14th by Infosys co-founder N. R. Narayan Murthy, seeks to bridge the gap in cancer research, where less than 10% of genomic data represents the over 70% of cancer patients residing in Asia, West Asia, and Latin America.
4baseCare states that GCDA, built using real-world data from India and the Global South, is the most inclusive cancer genomics dataset currently available. The company says GCDA is designed to enable the development of diagnostics, conduct inclusive research, and improve cancer care. By integrating region-specific genomic insights, GCDA aims to empower clinicians with tools for more accurate diagnoses and targeted treatments, potentially eliminating misdiagnoses and enhancing patient outcomes worldwide.
In addition to the atlas launch, Mr. Murthy also inaugurated 4baseCare’s new genomics lab in Mahadevapura, Bengaluru. The lab will provide advanced genomic testing solutions, including comprehensive gene panels, whole exome sequencing, and transcriptome analysis.
The initiative is a significant step towards ensuring equitable cancer care and research that reflects the global diversity of cancer patients.
First Piper 